Pet obesity market is predicted to reach USD 1.87 billion at a CAGR of 7.28% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Pet obesity market”.

The pet obesity market is attributed to register a CAGR of 7.28% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global pet obesity market— Pfizer Animal Health (US), Colgate-Palmolive Company (US), Royal Canin (France), Vivaldis (India), Pedigree (US), Park Vet Group (UK), Purina (US), Blue Buffalo Co., Ltd. (US), Eukanuba (Australia), Farmina (Italy), and others.

Market Highlights

The global pet obesity market is estimated to register a CAGR of 7.28% during the forecast period and is projected to reach USD 1.87 billion by 2032.

The pet obesity market is booming, driven by a confluence of trends such as pet obesity and the rise of health-conscious pet owners. According to the Association for Pet Obesity Prevention, 59% of dogs and 61% of cats had obesity in 2022. Another one of the most significant factors is the increasing awareness of pet health and well-being among owners. As pets become more integrated into family life, people are becoming more invested in their long-term health and happiness. This has led to a growing demand for products and services that help manage pet weight and prevent obesity-related health problems. Furthermore, there are several other key trends driving the pet obesity market, including the humanization of pets. People are increasingly treating their pets like family members, and they are willing to spend more money on their health and well-being. This has led to a surge in the popularity of premium pet food, supplements, and other obesity management solutions.

However, the lack of awareness about food supplements among pet parents is retarding the market's growth. Moreover, growing expenditure on pet healthcare, personalized nutrition, telehealth, and online services seemed to provide flourishing opportunities for the pet obesity market.

Access full report @ https://www.marketresearchfuture.com/reports/pet-obesity-market-12160

Segment Analysis

The global pet obesity market has been segmented based on animal type, product, and distribution channel.

On the basis of animal type, the market is segmented into dogs, cats, horses, and others. The dog segment held the largest market share in 2022 due to an expanding middle class and an increasing pet population.  Health for Animals estimated in September 2022 that dogs are the most popular pet worldwide, with one in every three households owning one.

Based on product, the global pet obesity market has been segmented into drugs and food supplements. Furthermore, the food supplements are segmented into protein, carbohydrate and fat, fibre, and others. The food supplements segment dominated the market in 2022 and was the fastest-growing segment during the forecast period. This is due to increasing awareness about pet supplements and the rising competition among pet supplement manufacturers as they launch innovative products. For instance, in October 2023, Native Pet (US) launched all-in-one supplements for dogs that provide energy, improve skin and coat health, enhance mobility, and improve gut health.

The global pet obesity market, based on distribution channels, has been segmented into veterinary hospitals, pet specialty stores, e-commerce, and others. The veterinary hospitals segment held the largest market share in 2022, and e-commerce is the fastest-growing segment during the forecast period, i.e., 2023–2032. Moreover, veterinary hospitals are the major contributors to the pet obesity market. By providing specialized services, utilizing technology, and raising awareness about pet obesity, veterinary hospitals can position themselves to capture a larger share of this growing market and contribute to improved pet health and well-being.

Regional Analysis

The global pet obesity market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America consists of the US and Canada. The Europe pet obesity market comprises Germany, France, the UK, Italy, Spain, and the rest of Europe. The pet obesity market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World pet obesity market comprises the Middle East, Africa, and Latin America.

The North America pet obesity market held the largest market share in 2022 due to factors such as the increasing pet population and the presence of major players including Pfizer Animal Health (US), Colgate-Palmolive Company (US), Pedigree (US), and others. According to the Health for Animals, approximately 70% of households own a pet as of 2021, compared to 68% in 2016.

Furthermore, the European pet obesity market shows significant growth during the forecast period owing to factors such as increasing pet ownership, which in turn increases demand for pet services and products. As per the European Pet Food, there was 46% percent growth in pet ownership in Europe by 2022.  

Moreover, the Asia-Pacific pet obesity market is representing the highest annual growth rate during the forecast period due to market expansion in order to fulfill the demand of consumers. For instance, in March 2022, Archer-Daniels-Midland Company (US) launched Equilibrio, a pet food brand, into the Chinese market. The brand offers diets that address specific health conditions, including weight management.

Also, the rest of the world is made up of the Middle East, Africa, and Latin America. The region shows sluggish growth during the forecast period due to a lack of awareness of food supplements among pet parents. However, the frequent expansion of the market through investing is fueling the growth of the market in Africa. For instance, in September 2022, Montego Pet Nutrition (South Africa) invested approximately USD 2 million to open new manufacturing facilities.

Key Findings of the Study

• The global pet obesity market is expected to reach USD 1.87 billion by 2032, at a CAGR of 7.28% during the forecast period.


• The Europe region shows significant growth during the forecast period due to the presence of major players and growing pet ownership.


• Based on product, the food supplement segment held the largest market share in 2022, with an approximate market share of 50% to 65%.


• Pfizer Animal Health (US), Colgate-Palmolive Company (US), Royal Canin (France), Vivaldis (India), Pedigree (US), Park Vet Group (UK), Purina (US), Blue Buffalo Co., Ltd. (US), Eukanuba (Australia), Farmina (Italy), and others are the key market players.